NSEBSE
There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-
MARKET DEPTH
Total bid0.00
Total ask0.00
HIGH/LOW
LOW/HIGH
₹1,735.002 days ago
₹1,790.702 days ago
Concord Biotech Limited is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology, supplying too many countries including regulated markets, such as the United States, Europe and Japan and India. It commanded a market share of over 20% by volume in 2022 across identified fermentation-based API products, including mupirocin, sirolimus, tacrolimus, mycophenolate sodium and cyclosporine. In 2016, it launched its formulation business in India as well as emerging markets, including Nepal, Mexico, Indonesia, Thailand, Ecuador, Kenya, Singapore and Paraguay, and have further expanded to the United States.
